戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              BCV Drep RNA that lacked a poly(A) tail did not replicat
2                                              BCV is a prototype for the coronaviruses that express an
3                     MAb Z3A5 reacted with 90 BCV isolates from the United States and was an effective
4        This is the first identification of a BCV packaging signal.
5 y with Z3A5 and in situ hybridization with a BCV nucleoprotein cDNA probe.
6 (5) PFU of IHD-J-Luc VACV without additional BCV treatment.
7                                          All BCV-treated mice that survived challenge were also prote
8                                          All BCV-treated mice that survived infection were protected
9                                      ACS and BCV on the mastoid caused higher asymmetry compared to B
10                                      ACS and BCV with the B81on the mastoid evoked cVEMPs in 100% of
11  the nucleoprotein gene sequences of ECV and BCV was observed.
12 chi Calossi Versaci front index (BCV(f)) and BCV back index (BCV(b)), root mean square of front and b
13 stoid, BCV with the B81 on the forehead, and BCV with the Mini-Shaker 4810 on the forehead.
14 ia monocytogenes, a Gram-positive bacterium, BCV rupture by Gram-negative pathogens such as Shigella
15      RNA transcripts were packaged into both BCV and MHV virions when the cloned region was appended
16 g superior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV) and internal jugular vein (IJV).
17 s used to study the effect of brincidofovir (BCV) in normal and immune-deficient (nu/nu) mice infecte
18 stchallenge administration of brincidofovir (BCV, CMX001) was studied in normal and immune-deficient
19 rucella replication in the ER is followed by BCV conversion into a compartment with autophagic featur
20 or two group II viruses, bovine coronavirus (BCV) and mouse hepatitis coronavirus (MHV).
21 igenic relationship with bovine coronavirus (BCV) and porcine hemagglutinating encephalomyelitis viru
22         We have used the bovine coronavirus (BCV) as a model to study interactions between the viral
23          A region of the bovine coronavirus (BCV) genome that functions as a packaging signal has bee
24 spike protein subunit of bovine coronavirus (BCV) reacted with the virus in formalin-fixed intestines
25 nst the spike protein of bovine coronavirus (BCV), on an indirect fluorescent antibody test.
26 eplaced by the 3' UTR of bovine coronavirus (BCV), which diverges overall by 31% in nucleotide sequen
27                   Using previously described BCV primers, the N protein gene of isolate NC99 was ampl
28 ine (BCNU), cyclophosphamide, and etoposide (BCV) preparative regimen (27 patients) and an ABMT at 16
29                   Amplitudes were higher for BCV than ACS.
30  a published nucleoprotein gene sequence for BCV (Mebus isolate), we arbitrarily designed two primers
31         Replication of the defective genomes BCV Drep and MHV MIDI-C, along with several mutants, was
32 aci front index (BCV(f)) and BCV back index (BCV(b)), root mean square of front and back corneal surf
33 rface, Baiocchi Calossi Versaci front index (BCV(f)) and BCV back index (BCV(b)), root mean square of
34                                   Initiating BCV treatment earlier was more efficient in reducing vir
35             A three-dose regimen of 20 mg/kg BCV administered every 48 h starting either on day 1 or
36     Postchallenge administration of 20 mg/kg BCV rescued normal and immune-deficient mice partially r
37  oVEMPs: to BCV with the B81 on the mastoid, BCV with the B81 on the forehead, and BCV with the Mini-
38 sed as an approved medical device to measure BCV VEMPs in a clinical set-up.
39                    In immune-deficient mice, BCV extended survival.
40                    In immune-deficient mice, BCV protected animals from lethality and reduced viral l
41 n IpaH7.8 promotes Rab13 retention on moving BCV membrane remnants, thereby facilitating membrane unc
42 as an effective reagent for the diagnosis of BCV.
43  an abundant lipid of the luminal leaflet of BCV membranes, and normally absent from the cytosol, bec
44 the cytosol as an early predictive marker of BCV rupture by Gram-negative bacteria.
45  sequence of NC99 and published sequences of BCV (Mebus and F15 strains) and human coronavirus (strai
46 of both ECV isolates were similar to that of BCV as determined by sodium dodecyl sulfate-polyacrylami
47         Moreover, the efficient unpeeling of BCV remnants contributes to a successful intercellular s
48 ectron microscopy (CLEM), we discovered that BCV rupture proceeds through two distinct successive sta
49                           The data show that BCV controls viral replication at the site of challenge
50            Together, these data suggest that BCV protects immunocompetent and partially T cell-recons
51 host-pathogen interactions that occur at the BCV membrane is limited by the difficulty in purifying m
52 CUAAAC element which occurs only once in the BCV 5' untranslated region was either deleted or complet
53  substitution of a particular portion of the BCV 3' UTR for the corresponding region of the MHV 3' UT
54 acuoles (BCVs) and subsequent rupture of the BCV membrane, thereby exposing to the cytosol intralumin
55 anslocated into the cytosolic leaflet of the BCV, invariably followed by cytosolic exposure of glycan
56                The data demonstrate that the BCV genome contains a sequence that is conserved at both
57 nd redirecting Golgi-derived vesicles to the BCV.
58  Specific host protein interactions with the BCV 3' UTR [287 nt plus poly(A) tail] were identified us
59 ely related genetically and antigenically to BCV and will be a new member of antigenic group 2 of the
60  mastoid caused higher asymmetry compared to BCV forehead stimulation.
61 he B81 transducer on the mastoid; oVEMPs: to BCV with the B81 on the mastoid, BCV with the B81 on the
62 them escape the bacteria-containing vacuole (BCV) and colonize the cytosol.
63  by forming the Brucella-containing vacuole (BCV), which traffics from the endocytic compartment to t
64 membrane-bound bacterium-containing vacuole (BCV).
65         cVEMPs: to bone conducted vibration (BCV) with the B81 transducer on the mastoid; oVEMPs: to
66 with 10(4) PFU of IHD-J-Luc and treated with BCV postchallenge survived the infection, cleared the vi